Astral Codex Ten

ARPA-H

3 min read

ARPA-H

Article

ARPA-H is a recurring organization in the Astral Codex Ten archive, appearing 2 times across 2 issues between November 04, 2022 and February 07, 2025. The archive places it in contexts such as “advising ARPA-H (the new “DARPA for health”) on meta-science issues”; “Release ARPA-H from the NIH”; “ARPA-H is an innovative government science funder modeled after DARPA”. It most often appears alongside 1DaySooner, ACX, Johns Hopkins.

Metadata

  • Category: Organizations
  • Mention count: 2
  • Issue count: 2
  • First seen: November 04, 2022
  • Last seen: February 07, 2025

Appears In

Source Context

Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.

ACX Grants: Project Updates
November 04, 2022 · Original source
37: Good Science Project, Working To Improve Federal Science Funding (?/10) The Good Science Project officially launched back in April, and has brought on a Senior Fellow (Betsy Ogburn of Johns Hopkins, with an interest in clinical trial quality and infrastructure) and Eric Gilliam (formerly working for Steve Levitt, with an interest in progress studies and the creation of effective scientific institutions). They have published many articles on science reform, most recently including a Health Affairs piece arguing for an NIH Center of Innovation, and are advising ARPA-H (the new “DARPA for health”) on meta-science issues. Staffers at the White House and Congress regularly ask for their input. You can read their Substack here.
Inline links: Health Affairs piece, their Substack here
1DaySooner's Trump II Health Policy Proposals
February 07, 2025 · Original source
Release ARPA-H from the NIH: Bhattacharya likes unorthodox things, and the most unorthodox thing you can do in DC is to deliberately decrease the size of your empire. ARPA-H is an innovative government science funder modeled after DARPA. Although it was intended as an independent agency, it got placed within NIH due to bureaucratic machinations. Now it’s in danger of getting shoved into a new National Institute on Innovation and Advanced Research with a lower budget. Separating ARPA-H from the NIH will protect it it from this fate, help it deliver on its intended goals, and help NIH reducing the number of institutes and centers it oversees (granting more research dollars per center).
Inline links: ARPA-H, intended as